When was Aurobindo Pharma founded?

Aurobindo Pharma was founded in 1986 and raised its 1st funding round 25 years after it was founded.

Where is Aurobindo Pharma located?

Aurobindo Pharma is headquartered in Hyderabad, India. It is registered at PLOT NO.2, MAITHRIVIHAR, BEHIND MAITHRI VANAM, AMEERPET, HYDERABAD, Telangana, India, 500038.

How many employees does Aurobindo Pharma have?

As of Mar 31, 2025, Aurobindo Pharma has 27707 employees, reflecting a 313% year-over-year growth in headcount.

Is Aurobindo Pharma a funded company?

Aurobindo Pharma is a funded company, having raised an undisclosed amount across 2 funding rounds to date. The company's 1st funding round was a $***** Post IPO round, raised on Apr 2011.

When was the latest funding round of Aurobindo Pharma?

Aurobindo Pharma's latest funding was a $***** Post IPO round on Jul 2017, with participation from 1 investor. Its primary sector is Traditional Pharmaceuticals. In India, the Traditional Pharmaceuticals sector has seen $800M in funding in 2026 to date.

What is the annual revenue of Aurobindo Pharma?

Annual revenue of Aurobindo Pharma is more than ₹1,000 Cr as on Mar 31, 2026

Where does Aurobindo Pharma rank among its competitors?

Aurobindo Pharma ranks 9th amongst 206 active competitors, of which 13 are funded. It stands 9th in terms of total funding among its competitors. The most recent competitor to raise funding was Dr. Reddy's Laboratories, which secured ₹30Cr in Feb, 2025.

Who are the top competitors of Aurobindo Pharma?

Aurobindo Pharma's top competitors include Bayer, Wockhardt and Lupin. Among them, Dr. Reddy's Laboratories secured the most recent funding round in February, 2025.

Aurobindo Pharma - 2026 Company Profile, Team, Funding, Competitors & Financials

Company Details

Provider of generic biocatalytic products. It develops, manufactures, and commercializes a wide range of generic pharmaceuticals, active pharmaceutical ingredient, and injectables. It offers innovative products, packaging, and merchandising solutions.

Website: www.aurobindo.com/
Social
Email ID: *****@aurobindo.com
Phone Number: +91 **********
Registered Address: PLOT NO.2, MAITHRIVIHAR, BEHIND MAITHRI VANAM, AMEERPET, HYDERABAD, Telangana, India, 500038

Key Metrics

Founded Year

1986

Location

Hyderabad, India

Stage

Public

Latest Funding Round

Post IPO, Jul 2017, $*****

Investors

Affirma Capital & 5 more

Ranked

9^th among 206 active competitors

Annual Revenue

₹1,000+ Cr as on Mar 31, 2026

Employee Count

27,707 as on Mar 31, 2025

Investment & Acquisitions

Tergene Biotech & 10 more

Similar Companies

Bayer & 219 more

Exit Details

Public

View Aurobindo Pharma's full profile

Aurobindo Pharma is associated with 18 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count
AURO VACCINES PRIVATE LIMITED CIN: U24297TG2021PTC156684 , India, Active	Nov 08, 2021	₹10 - ₹50 Cr (As on Mar 31, 2025)	60 (As on Apr 30, 2026)
Aurovitas, spol. s r.o. CIN: 45314306 , Czech Republic, Active	Mar 17, 1992	-	-
AUROBINDO PHARMA FOUNDATION CIN: U85200TG2020NPL141954 , India, Active	Jul 20, 2020	₹50 - ₹100 Cr (As on Mar 31, 2025)	17 (As on Apr 30, 2026)
SILICON LIFE SCIENCES PRIVATE LIMITED CIN: U85100TG2008PTC057669 , India, Amalgamated	Feb 19, 2008	₹100 - ₹500 Cr (As on Mar 31, 2020)	135 (As on Apr 30, 2021)
AUROZEST PRIVATE LIMITED CIN: U24299TG2020PTC142578 , India, Active	Aug 06, 2020	0 - ₹10 Cr (As on Mar 31, 2025)	-
APITORIA PHARMA PRIVATE LIMITED CIN: U24298TG2017PTC121342 , India, Active	Dec 20, 2017	₹1,000+ Cr (As on Mar 31, 2025)	4766 (As on Apr 30, 2026)
APL HEALTHCARE LIMITED CIN: U24239TG2006PLC052053 , India, Active	Dec 19, 2006	₹1,000+ Cr (As on Mar 31, 2025)	1308 (As on Apr 30, 2026)
AUROZYMES LIMITED CIN: U24232TG2013PLC091383 , India, Amalgamated	Nov 28, 2013	0 - ₹10 Cr (As on Mar 31, 2020)	-
CUREPRO PARENTERALS LIMITED CIN: U24232TG2013PLC087101 , India, Amalgamated	Apr 19, 2013	0 - ₹10 Cr (As on Mar 31, 2020)	-
AURO PEPTIDES LIMITED CIN: U24232TG2012PLC078350 , India, Active	Jan 02, 2012	₹10 - ₹50 Cr (As on Mar 31, 2025)	134 (As on Apr 30, 2026)
HYACINTHS PHARMA PRIVATE LIMITED CIN: U24232TG2010PTC069638 , India, Amalgamated	Jul 23, 2010	0 - ₹10 Cr (As on Mar 31, 2020)	23 (As on Mar 31, 2021)
MVIYES PHARMA VENTURES PRIVATE LIMITED CIN: U74999TG2017PTC116265 , India, Amalgamated	Mar 30, 2017	0 - ₹10 Cr (As on Mar 31, 2023)	-
AUROACTIVE PHARMA PRIVATE LIMITED CIN: U24230TG2020PTC138313 , India, Active	Jan 09, 2020	₹10 - ₹50 Cr (As on Mar 31, 2025)	300 (As on Apr 30, 2026)
APL RESEARCH CENTRE LIMITED CIN: U24116TG2006PLC051171 , India, Amalgamated	Sep 15, 2006	0 - ₹10 Cr (As on Mar 31, 2020)	-
CURATEQ BIOLOGICS PRIVATE LIMITED CIN: U24110TG2020PTC140190 , India, Active	Apr 25, 2020	0 - ₹10 Cr (As on Mar 31, 2025)	780 (As on Apr 30, 2026)
AURONEXT PHARMA PRIVATE LIMITED CIN: U74999TG2009PTC109591 , India, Amalgamated	Jul 02, 2009	0 - ₹10 Cr (As on Mar 31, 2023)	339 (As on Jan 31, 2021)
AUROBINDO PHARMA LTD CIN: L24239TG1986PLC015190 , India, Active	Dec 26, 1986	₹1,000+ Cr (As on Mar 31, 2026)	26015 (As on Mar 31, 2024)
TERGENE BIOTECH LIMITED CIN: U24230TG2008PLC113178 , India, Active	Mar 07, 2008	0 - ₹10 Cr (As on Mar 31, 2026)	-

Aurobindo Pharma got listed on Jun 04, 1995.

Click here to take a look at Aurobindo Pharma's IPO in detail

Aurobindo Pharma has raised funding over 2 rounds. Its first funding round was on Apr 2011. Its latest funding round was a Post IPO round on Jul 2017 for $*****. 1 investor participated in its latest round. Aurobindo Pharma has 6 institutional investors.

Here is the list of recent funding rounds of Aurobindo Pharma:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jul 2017	3378353	Post IPO	6222260	3223338	4021336	8862599
Apr 2011	8798658	Post IPO	1396219	8333732	9949529	Templeton Private Equity Partners

Access funding benchmarks and valuations. Sign up today!

View details of Aurobindo Pharma's funding rounds and investors

The founders of Aurobindo Pharma are Venkata Ramprasad Reddy V Ramprasad Penaka and Nityananda Reddy Nityananda Kambam.

Here are the details of Aurobindo Pharma's key team members:

Venkata Ramprasad Reddy V Ramprasad Penaka: Co-Founder of Aurobindo Pharma. They serve on the board of 1 company.
Contact Info: 1 email address
Nityananda Reddy Nityananda Kambam: Co-Founder, MD & VC of Aurobindo Pharma. They serve on the board of 1 company.
Contact Info: 1 email address

Aurobindo Pharma's Board of Directors

Aurobindo Pharma's board has 8 active members. Venkata Ramprasad Reddy V Ramprasad Penaka and Nityananda Reddy Nityananda Kambam are part of team and Punita Kumar Sinha, Girish Paman Vanvari, Santanu Mukherjee, Satakarni Makkapati, Sarath Chandra Reddy Chandra Reddy Penaka and Madan Mohan Reddy Mohan Reddy Mettu are independent board members.

Here is the list of Aurobindo Pharma's board of directors:

Name	Type	Representing	Status	Duration
Venkata Ramprasad Reddy V Ramprasad Penaka	Team	-	Current	33y 10m
Nityananda Reddy Nityananda Kambam	Team	-	Current	33y 10m
Girish Paman Vanvari	Independent board member	-	Current	5y 11m
ulumbok	Independent board member	-	Current	4y 9m
gbr{tpu	Independent board member	-	Current	9y 6m
mnctioj	Independent board member	-	Current	3y 3m
ieemjpy	Independent board member	-	Current	3y 5m
ojfqkro	Independent board member	-	Past	8y 9m

View details of Aurobindo Pharma's Founder profiles and Board Members

Aurobindo Pharma's employee count trend

Aurobindo Pharma has 27,707 employees as of Mar 25. The total employee count is 7.0% more than what it was in Mar 24. Here is Aurobindo Pharma's employee count trend over the years:

Employee count trend for Aurobindo Pharma

Uncover Aurobindo Pharma's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Aurobindo Pharma include Bayer, Wockhardt and Lupin. Here is the list of Top 10 competitors of Aurobindo Pharma, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Bayer 1863, Leverkusen (Germany), Public	Manufacturer of drugs	-	Digital Pharma Lab, B Capital Fund & 9 others	76/100
2nd	Wockhardt 1967, Mumbai (India), Public	Manufacturer of pharmaceuticals, biotechnology products, and active pharmaceutical ingredients	-	HDFC Mutual Fund, Tata Mutual Fund & 12 others	71/100
3rd	Lupin 1968, Mumbai (India), Public	Manufacturer of pharmaceutical products, including generics, biosimilars, and active pharmaceutical ingredients	$6.64M	Cipher International, AbbVie & 5 others	71/100
4th	Biological E 1953, Hyderabad (India), Funding Raised	Developer of vaccines for treating multiple diseases	-	Gates, IFC & 3 others	69/100
5th	Cipla 1935, Mumbai (India), Public	Manufacturer of APIs, generic drugs, and formulation development services	-	MUFG, Eight Roads Ventures & 3 others	69/100
6th	Emcure 1981, Pune (India), Public	Developer, manufacturer, and markets a broad range of pharmaceutical products	$50M	Blackstone, Bain Capital	68/100
7th	Amneal 2002, Bridgewater (United States), Public	Manufacturer of generics formulations	-	Tarsadia, GE Capital & 2 others	68/100
8th	Strides Pharma Science 1990, Bengaluru (India), Public	Manufacturer of generic pharmaceutical products and various specialty medical formulations	-	InvAscent, Oman India Joint Investment Fund ... & 3 others	68/100
9th	Aurobindo Pharma 1986, Hyderabad (India), Public	Provider of generic biocatalytic products	-	Affirma Capital, India Capital Growth & 4 others	66/100
10th	Dr. Reddy's Laboratories 1984, Hyderabad (India), Public	Multinational pharmaceutical company that develops and manufactures innovative and medicines to improve patient health	-	Life Insurance Corporation of India, Gates ... & 4 others	65/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Aurobindo Pharma's competitors? Click here to see the top ones

AUROBINDO PHARMA LTD, the legal entity associated with Aurobindo Pharma, generated more than ₹1,000 Cr in revenue for the financial year ending on Mar 31, 2026. The revenue of AUROBINDO PHARMA LTD has a compounded annual growth rate (CAGR) of 6% in the last 1 year.

Financial Statement Summary

Metrics	FY 2025-26	FY 2024-25	FY 2023-24	FY 2022-23	FY 2021-22
Income Statement
Revenue	3518	1647	1349	4005	5481
Total Sales	8890	9918	9819	8657	2662
Total Expenses	2342	8541	2944	9750	9659
Operating Expenses	7658	9973	8428	6505	2668
Employee Expenses	9709	1899	9793	4122	4446
Operating Income (EBIT)	5134	2825	5158	6017	6496
Interest Expenses	1253	8352	5339	4996	7680
Expenses from other activities	7794	4722	7195	3660	5126
Information Technology Expenses	2945	8000	2517	8427	2618
EBITDA	8261	5785	7198	8237	7878
Taxes	3859	6442	7994	4888	6998
Net Profit	1516	6379	3300	6146	2265
Balance Sheet
Assets	9550	8913	3609	2211	4538
Cash Equivalent	8420	2483	7669	5932	5499
Accounts Receivables	1688	4009	3002	8389	8984
Inventory	1290	5373	4418	8635	5939
Liabilities	1347	2907	5490	8725	2562
Total Debt	8902	2459	9525	3231	4285
Accounts Payable	7061	1308	8367	4443	3622
Equities	9639	2685	2369	7662	3788
Cashflow Statement
Cash from Operating activities	7255	6057	8584	9735	3512
Cash from Investing activities	6648	8130	4313	3017	2434
Net cash from Financing activities	4981	6803	7425	2076	1232

Detailed Financials (Income Statement, Balance Sheet, Cashflow Statement)

Aurobindo Pharma has made 3 investments in companies including NVNR Ramannapet II Power Plant and NVNR Ramannapet I Power Plant. Aurobindo Pharma has also acquired 8 companies including Tergene Biotech and GLS Pharma.

Here is the list of investments & acquisitions:

Filter this list

Date of Investment/Acquisition	Type	Company Name	Founded Year	Location
Feb 26, 2025	Acquisition	Tergene Biotech	2008	Hyderabad (India)
Jun 17, 2022	Acquisition	GLS Pharma	2004	Delhi (India)
Mar 28, 2022	Acquisition	Veritaz Healthcare	2007	Hyderabad (India)